NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 937 filers reported holding NOVARTIS A G in Q3 2017. The put-call ratio across all filers is 0.64 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $653,000 | -81.1% | 6,896 | -82.8% | 0.01% | -78.3% |
| Q3 2018 | $3,446,000 | -60.1% | 40,000 | -65.0% | 0.02% | -52.1% |
| Q2 2018 | $8,635,000 | +232.9% | 114,309 | +256.3% | 0.05% | +242.9% |
| Q1 2018 | $2,594,000 | +290.7% | 32,080 | +305.8% | 0.01% | +366.7% |
| Q4 2017 | $664,000 | -76.3% | 7,905 | -76.5% | 0.00% | -84.2% |
| Q2 2017 | $2,804,000 | +26.0% | 33,588 | +12.1% | 0.02% | +11.8% |
| Q1 2017 | $2,226,000 | +364.7% | 29,975 | +393.9% | 0.02% | +750.0% |
| Q3 2016 | $479,000 | +116.7% | 6,069 | +99.0% | 0.00% | +100.0% |
| Q1 2016 | $221,000 | +76.8% | 3,050 | +140.3% | 0.00% | 0.0% |
| Q2 2015 | $125,000 | -91.7% | 1,269 | -91.7% | 0.00% | -87.5% |
| Q1 2015 | $1,514,000 | -34.7% | 15,352 | -37.6% | 0.01% | -46.7% |
| Q3 2014 | $2,318,000 | -43.7% | 24,620 | -49.1% | 0.02% | -62.5% |
| Q1 2014 | $4,116,000 | +80.2% | 48,413 | +70.3% | 0.04% | +185.7% |
| Q4 2013 | $2,284,000 | – | 28,420 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MANAGED ASSET PORTFOLIOS, LLC | 332,962 | $27,452,000 | 7.32% |
| Mawer Investment Management Ltd. | 7,721,327 | $636,623,000 | 5.86% |
| Martin Investment Management, LLC | 133,246 | $10,986,000 | 5.56% |
| SCHARF INVESTMENTS, LLC | 1,330,175 | $109,673,000 | 5.48% |
| Hansberger Growth Investors, LP | 46,663 | $3,847,000 | 5.19% |
| Bain Capital Public Equity Management II, LLC | 440,233 | $36,297,000 | 4.25% |
| First Fiduciary Investment Counsel, Inc. | 187,633 | $15,470,000 | 4.10% |
| GARLAND CAPITAL MANAGEMENT INC | 53,555 | $4,416,000 | 4.02% |
| Lowell Blake & Associates Inc. | 37,219 | $3,069,000 | 3.94% |
| PRENTISS SMITH & CO INC | 68,027 | $5,609,000 | 3.89% |